Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CELU
CELU
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CELU News
Celularity Faces Nasdaq Compliance Issue
2d ago
seekingalpha
CELULARITY RECEIVES NASDAQ NOTICE FOR DELAYED FORM 10-K FILING
3d ago
moomoo
NEXGEL INC - Agreement Anticipated to Increase Annual Revenue to $35 Million and Achieve Profitability at Closing
Mar 12 2026
moomoo
NEXGEL INC: $15 Million Upfront Cash and Potential $20 Million in Milestone Payments Included in Consideration
Mar 12 2026
moomoo
NEXGEL Reveals Terms for Licensing and Acquiring a Portfolio of Commercial Regenerative Biomaterial Products
Mar 12 2026
moomoo
Celularity Enters Strategic Partnership for Biomaterials
Mar 10 2026
seekingalpha
NexGel Expects Revenue to Triple
Mar 10 2026
Benzinga
NEXGEL INC ANTICIPATES COMPLETING $14.9 MILLION IN EXTRA FINANCING BY Q1 OR EARLY Q2 2026
Mar 10 2026
moomoo
Celularity Enters Strategic Partnership for Biomaterials Portfolio
Mar 10 2026
Newsfilter
Celularity Secures $12.2 Million from Sale of Tax Credits and NOLs
Feb 10 2026
Newsfilter
Celularity's Biovance Products to Maintain Medicare Coverage Post LCD Withdrawal
Dec 29 2025
NASDAQ.COM
Celularity Withdraws Skin Substitute LCDs; Biovance® Remains Medicare Eligible
Dec 26 2025
Globenewswire
Celularity Responds to CMS Withdrawal of Skin Substitute Policies
Dec 26 2025
Newsfilter
Celularity Secures $10 Million Financing to Enhance Financial Flexibility
Dec 22 2025
Globenewswire
Celularity Secures $12 Million Financing to Support Strategic Priorities
Dec 18 2025
Newsfilter
Celularity Secures $12 Million Financing to Support Strategic Priorities
Dec 18 2025
Globenewswire
Show More News
